XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Deficit (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Total Athenex, Inc. Stockholders' Equity
Non-Controlling Interests
Beginning balance at Dec. 31, 2020 $ 165,348 $ 95 $ 901,864 $ (713,644) $ (1,134) $ (7,406) $ 179,775 $ (14,427)
Beginning balance, shares at Dec. 31, 2020   95,066,195       (1,672,920)    
Stock-based compensation cost 2,205   2,205       2,205  
Restricted stock expense 29   29       29  
Stock options exercised 852   852       852  
Stock options exercised, shares   119,425            
Net loss (25,603)     (25,050)     (25,050) (553)
Other comprehensive income (loss), net of tax 293       293   293  
Ending balance at Mar. 31, 2021 143,124 $ 95 904,950 (738,694) (841) $ (7,406) 158,104 (14,980)
Ending balance, shares at Mar. 31, 2021   95,185,620       (1,672,920)    
Beginning balance at Dec. 31, 2020 165,348 $ 95 901,864 (713,644) (1,134) $ (7,406) 179,775 (14,427)
Beginning balance, shares at Dec. 31, 2020   95,066,195       (1,672,920)    
Net loss (60,218)              
Ending balance at Jun. 30, 2021 169,880 $ 111 966,666 (772,968) (1,123) $ (7,485) 185,201 (15,321)
Ending balance, shares at Jun. 30, 2021   110,980,660       (1,672,920)    
Beginning balance at Dec. 31, 2020 165,348 $ 95 901,864 (713,644) (1,134) $ (7,406) 179,775 (14,427)
Beginning balance, shares at Dec. 31, 2020   95,066,195       (1,672,920)    
Ending balance at Dec. 31, 2021 34,452 $ 111 972,404 (913,412) (487) $ (7,485) 51,131 (16,679)
Ending balance, shares at Dec. 31, 2021   111,802,968       (1,672,920)    
Beginning balance at Mar. 31, 2021 143,124 $ 95 904,950 (738,694) (841) $ (7,406) 158,104 (14,980)
Beginning balance, shares at Mar. 31, 2021   95,185,620       (1,672,920)    
Sale of common stock, shares   33,373            
Sale of common stock 133   133       133  
Issuance of common stock in connection with acquisition of Kuur and settlement of transaction incentive liability assumed, shares   15,601,667            
Issuance of common stock in connection with acquisition of Kuur and settlement of transaction incentive liability assumed 58,428 $ 16 58,412       58,428  
Stock-based compensation cost 2,387   2,387       2,387  
Restricted stock expense 57   57       57  
Stock options exercised 727   727       727  
Stock options exercised, shares   160,000            
Treasury stock repurchase (79)         $ (79) (79)  
Net loss (34,615)     (34,274)     (34,274) (341)
Other comprehensive income (loss), net of tax (282)       (282)   (282)  
Ending balance at Jun. 30, 2021 169,880 $ 111 966,666 (772,968) (1,123) $ (7,485) 185,201 (15,321)
Ending balance, shares at Jun. 30, 2021   110,980,660       (1,672,920)    
Beginning balance at Dec. 31, 2021 34,452 $ 111 972,404 (913,412) (487) $ (7,485) 51,131 (16,679)
Beginning balance, shares at Dec. 31, 2021   111,802,968       (1,672,920)    
Sale of common stock through ATM shares   1,646,026            
Sale of common stock through ATM 1,695 $ 2 1,693       1,695  
Stock-based compensation cost 1,623   1,623       1,623  
Restricted stock expense 251   251       251  
Issuance of warrants 148   148       148  
Net loss (17,932)     (17,420)     (17,420) (512)
Other comprehensive income (loss), net of tax 562       562   562  
Ending balance at Mar. 31, 2022 20,799 $ 113 976,119 (930,832) 75 $ (7,485) 37,990 (17,191)
Ending balance, shares at Mar. 31, 2022   113,448,994       (1,672,920)    
Beginning balance at Dec. 31, 2021 34,452 $ 111 972,404 (913,412) (487) $ (7,485) 51,131 (16,679)
Beginning balance, shares at Dec. 31, 2021   111,802,968       (1,672,920)    
Net loss (50,306)              
Ending balance at Jun. 30, 2022 (5,473) $ 119 980,819 (962,989) 1,471 $ (7,485) 11,935 (17,408)
Ending balance, shares at Jun. 30, 2022   119,323,823       (1,672,920)    
Beginning balance at Mar. 31, 2022 20,799 $ 113 976,119 (930,832) 75 $ (7,485) 37,990 (17,191)
Beginning balance, shares at Mar. 31, 2022   113,448,994       (1,672,920)    
Sale of common stock through ATM shares   5,501,866            
Sale of common stock through ATM 2,780 $ 5 2,775       2,780  
Sale of common stock through ESPP shares   372,963            
Sale of common stock through ESPP 188 $ 1 187       188  
Stock-based compensation cost 1,358   1,358       1,358  
Restricted stock expense 245   245       245  
Issuance of warrants 135   135       135  
Net loss (32,374)     (32,157)     (32,157) (217)
Other comprehensive income (loss), net of tax 1,396       1,396   1,396  
Ending balance at Jun. 30, 2022 $ (5,473) $ 119 $ 980,819 $ (962,989) $ 1,471 $ (7,485) $ 11,935 $ (17,408)
Ending balance, shares at Jun. 30, 2022   119,323,823       (1,672,920)